We would love to hear your thoughts about our site and services, please take our survey here.
Thanks, spotted that also this evening, one of many promising avenues being researched.
Went back to look at this, may be helpful to some : https://www.valirx.com/our-pipeline
Just ordered a box of 10 to try out. Not a scam website, just all the signs of a new or small business family run company. Not quite joined up on the order page, they ask for details, then click. On the PayPal bit, go through to PayPal, then it completes the transaction and returns you to their site with order acknowledgment. You get a PayPal confirmation email and one from virion, but check your junk folder, as mine went in there as it was the first time they sent me anything. Excellent they cater for individual customers as well as businesses.
In all fairness, each to their own, everyone likes to feel they got a bargain but this morning I see a lot of comments about mid to late March as key news. Of course some ramping also evident in last nights posts, but would always expect someone who wants to make others pile in early, if news is really a good few weeks away. Apart from the random rns that’s been mentioned a few times, seems like a concensus is March/April......Just my gut feeling from a lot of other peoples gut feeling over the weekend.
Based on what’s been in the news about those antics, with a company as small as rms, that type of rallying would send the SP through the roof, skywards, never mind about the machine.
V low cap, rerate 40-60p (60 best case) no news, my analysis from few months ago (on hold while this was around the silly twenties) was 60-80 on moderate news, 80-150 on 1-2 sets of positive news (relating to 201 or Japan 301 license / progress for example). Still a v good hold in my view
This positive news angle more effectively distances this from run of the mill vaccine fodder and is making me believe that steps to reach the top end of the earlier £9.90-£50 brokers valuation are back in play and again, not unreasonable. Well done syn
Not an expert, but seems like confirmation of December info, nothing too new or boat rocking per say, longer term hold for the us revenues, and my view is this will also become a more attractive target to other bigger players, while they do that
good point, is there a way to see how many warrants remain? some big ones recently, and clearly those that had them have every right to gain from their investment choices if they wish. I'm just looking to try to determine what potential more large sell activity there could be
Lottohopes - thank you for your helpful reply, much appreciated, And I appreciate your patience and thoughtfulness in writing. there’s a lot of posts on this board, still working through them and developing a good feel now of which ones to filter. I got caught a bit in the science details trying to get my head around that, but it seems secure. Best of luck to you also!
New here, stumbled onto this forum from the share buyer article. Looks very positive and I’m starting to DMOR.
One question for those with more experience than me, I read there is no competition for this tech from a few on this board, but putting ‘anti viral mask’ into google, this is at the top of the list, https://www.hivepharmacy.com/aviro
Is this the same (OEM, or own brand version) or different (competition to P2P?), it has the ISO, a load of other certifications and states it is anti Covid and made in Switzerland. Are they working in collaboration with rms? And if not, what are the factors that make this different, is geographical market being Switzerland significant? Not a holder yet, but analysing more, would appreciate anyone’s considered insight, in case I am missing something.
Thank you
This is inhaled, don’t forget they talk about subcutaneous, from a medical and regulatory perspective, a completely different animal, no issues or change here, except maybe the need for sng just got a lot stronger
Numis changes everything, I blocked and filtered anyone In recent weeks with unsubstantiated wild upper prices for syn, and have been enjoying a relatively ramp and agenda free updates on what is essentially an excellent company and science and potential future case study. Honestly would not have thought of £9+, but the £50 (best case bullish, mind) valuation makes me want much more reward for this fantastic company and its supporters, than single digit share estimates now.
Got to be careful to read what’s in the RNS, not what we want it to say, in general, but in this case, wow! Positive, positive and positive, there is no other way to interpret this. Well done team Blautix!
Next 3-6 months will see this transform
From their website:
Numis is an ambitious, dynamic and innovative investment bank, driven to excel across all aspects of its delivery. We place long-term partnership at the very heart of our mission and strive to become the investment bank of a generation.
We are proud to have the largest client base by number of corporates in the UK, and through combining our leading component services such as M&A solutions, equity sales and trading and debt advisory, we operate at the very forefront of the industry with specialist expertise in the UK market.
a very good update in my view also. more secure cash position, pipeline sales activities and seems more positive news on the way. I didn't see much evidence of downplaying anything or talking around elephants in the room, even the US deal, not landed yet, was mentioned in a positive light, so short term seems very encouraging for q3-4.